Adjuvant therapy of melanoma: what's new?

Melanoma Res. 2002 Jun;12(3):293-6. doi: 10.1097/00008390-200206000-00015.
No abstract available

Publication types

  • Letter

MeSH terms

  • Chemotherapy, Adjuvant*
  • Clinical Trials as Topic
  • Clinical Trials, Phase III as Topic
  • Combined Modality Therapy
  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / adverse effects
  • Immunologic Factors / therapeutic use
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use
  • Lymph Node Excision
  • Melanoma / drug therapy*
  • Melanoma / mortality
  • Melanoma / surgery
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Risk
  • Survival Analysis
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Interferon-alpha